Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study.
02.28.2022 |
arrow_forward
Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo
01.13.2022 |
arrow_forward{"post_type":"post","orderby":"date","order":"DESC","posts_per_page":"12","category__in":""}